Effect of Anti-streptococcus antibody containing tablet on Streptococcus mutans count, causative factor of dental caries.

Effect of commercially available anti-streptococcus IgY containing tablet on Streptococcus mutans count in caries active children: In vivo study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023667

Enrollment

Registered

2020-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A488- Other specified bacterial diseases

Interventions

Intervention1: NoDecay Chew able Tablet: The tablet contains Egg Yolk protein powder (Delipidated), Mannitol, Maltitol, Xylitol, cross carmellose sodium, peppermint, orange flavour, microcrystalline c

Eligibility

Inclusion criteria

Inclusion criteria: Patients having 5 active carious teeth. Patients not requiring antibiotics. No systemic illness and pathology.

Exclusion criteria

Exclusion criteria: Use of systemic Antibiotics in last 30 days. Use of mouthwash in last 30 days. Allergic to egg.

Design outcomes

Primary

Measure	Time frame
Percent reduction in S Mutants count after administration of NoDecay chew able tablet.Timepoint: 1st day, 30th day, 90th day, 120th day, 180th day	—

Secondary

Measure	Time frame
Carious LesionTimepoint: 1. 90 Days 2. 180 Days	—

Countries

India

Contacts

Public ContactAditi mathur

DR D Y PATIL VIDYAPEETH

drmathuradi@gmail.com8376055529

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026